Arap1 loss causes retinal pigment epithelium phagocytic dysfunction and subsequent photoreceptor death.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 07 2022
Historique:
received: 12 10 2021
accepted: 16 06 2022
pubmed: 28 6 2022
medline: 27 7 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

Retinitis pigmentosa (RP), a retinal degenerative disease, is the leading cause of heritable blindness. Previously, we described that Arap1-/- mice develop a similar pattern of photoreceptor degeneration. Arap1 is an Arf-directed GTPase-activating protein shown to modulate actin cytoskeletal dynamics. Curiously, Arap1 expression was detected in Müller glia and retinal pigment epithelium (RPE), but not the photoreceptors themselves. In this study, we generated conditional knockout mice for Müller glia/RPE, Müller glia and RPE via targeting Rlbp1, Glast and Vmd2 promoters, respectively, to drive Cre recombinase expression to knock out Arap1. Vmd2-Cre Arap1tm1c/tm1c and Rlbp1-Cre Arap1tm1c/tm1c mice, but not Glast-Cre Arap1tm1c/tm1c mice, recapitulated the phenotype originally observed in germline Arap1-/- mice. Mass spectrometry analysis of human ARAP1 co-immunoprecipitation identified candidate binding partners of ARAP1, revealing potential interactants involved in phagocytosis, cytoskeletal composition, intracellular trafficking and endocytosis. Quantification of outer segment phagocytosis in vivo demonstrated a clear phagocytic defect in Arap1-/- mice compared to Arap1+/+ controls. We conclude that Arap1 expression in RPE is necessary for photoreceptor survival due to its indispensable function in RPE phagocytosis. This article has an associated First Person interview with the first author of the paper.

Identifiants

pubmed: 35758026
pii: 276063
doi: 10.1242/dmm.049343
pmc: PMC9346516
pii:
doi:

Substances chimiques

ARAP1 protein, human 0
Adaptor Proteins, Signal Transducing 0
Agtrap protein, mouse 0
Carrier Proteins 0
GTPase-Activating Proteins 0

Banques de données

figshare
['10.6084/m9.figshare.19225416']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NEI NIH HHS
ID : K08 EY027463
Pays : United States
Organisme : NEI NIH HHS
ID : K08 EY028199
Pays : United States
Organisme : NIH HHS
ID : UM1 OD023221
Pays : United States
Organisme : NIH HHS
ID : R03 OD032622
Pays : United States
Organisme : NIH HHS
ID : S10 OD026918
Pays : United States

Informations de copyright

© 2022. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

PLoS One. 2015 Mar 20;10(3):e0120415
pubmed: 25793273
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3495-502
pubmed: 19234351
Nat Genet. 2000 Nov;26(3):270-1
pubmed: 11062461
J Comp Neurol. 2006 Jan 10;494(2):368-79
pubmed: 16320245
Semin Immunol. 2001 Dec;13(6):347-55
pubmed: 11708890
J Exp Clin Cancer Res. 2018 Feb 13;37(1):28
pubmed: 29439719
Cell Death Dis. 2018 Dec 5;9(12):1183
pubmed: 30518789
J Biol Chem. 2014 May 2;289(18):12908-21
pubmed: 24634209
Invest Ophthalmol Vis Sci. 2009 May;50(5):2427-35
pubmed: 19117932
Physiology (Bethesda). 2010 Feb;25(1):8-15
pubmed: 20134024
Biol Cell. 2011 Apr;103(4):171-84
pubmed: 21275903
Mol Biol Cell. 2008 Apr;19(4):1717-26
pubmed: 18272790
Curr Genomics. 2011 Jun;12(4):238-49
pubmed: 22131869
Dev Cell. 2007 Nov;13(5):677-690
pubmed: 17981136
Int J Mol Sci. 2019 Jan 21;20(2):
pubmed: 30669557
J Biol Chem. 2018 Nov 9;293(45):17546-17558
pubmed: 30228185
Cell Motil Cytoskeleton. 2005 Sep;62(1):13-26
pubmed: 16001398
Mol Biol Cell. 2009 Sep;20(17):3896-904
pubmed: 19587120
Glia. 2013 May;61(5):651-78
pubmed: 23440929
EMBO Rep. 2018 Apr;19(4):
pubmed: 29467281
Int J Mol Sci. 2020 Aug 23;21(17):
pubmed: 32842471
Clin Ophthalmol. 2010 Apr 26;4:183-95
pubmed: 20463783
J Cell Sci. 2003 Sep 1;116(Pt 17):3453-61
pubmed: 12893809
Prog Retin Eye Res. 2018 Sep;66:157-186
pubmed: 29597005
Development. 2010 Sep;137(18):3037-46
pubmed: 20685736
Adv Exp Med Biol. 2014;801:97-103
pubmed: 24664686
Nat Cell Biol. 2010 Jul;12(7):696-702
pubmed: 20543839
Mol Biol Cell. 2005 Jul;16(7):3077-87
pubmed: 15829569
Traffic. 2002 May;3(5):331-41
pubmed: 11967127
Traffic. 2008 Dec;9(12):2236-52
pubmed: 18939958
Exp Eye Res. 2014 Sep;126:77-84
pubmed: 24485945
Mol Cell. 2002 Jan;9(1):109-19
pubmed: 11804590
Nat Methods. 2009 Jul;6(7):493-5
pubmed: 19525957
Orphanet J Rare Dis. 2006 Oct 11;1:40
pubmed: 17032466
J Biol Chem. 2007 Jan 19;282(3):1838-50
pubmed: 17085443
Development. 2019 Jan 9;146(1):
pubmed: 30567931
Am J Pathol. 2014 Jun;184(6):1660-7
pubmed: 24854863
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1709-1718
pubmed: 28324111
Exp Eye Res. 2013 Aug;113:9-18
pubmed: 23669303
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12005-10
pubmed: 17620600
Proteome Sci. 2009 Jun 16;7:21
pubmed: 19531213
Int J Mol Sci. 2019 Jul 22;20(14):
pubmed: 31336621
Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1378-83
pubmed: 21212186
Mol Vis. 2015 Apr 16;21:428-42
pubmed: 25991907
J Biol Chem. 2001 Oct 19;276(42):39271-6
pubmed: 11517213
Front Chem. 2014 Jul 07;2:45
pubmed: 25072053
iScience. 2018 Aug 31;6:199-211
pubmed: 30240610
J Biomed Biotechnol. 2010;2010:190724
pubmed: 20182540
J Comp Neurol. 2008 Sep 20;510(3):237-50
pubmed: 18626943
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):893-905
pubmed: 18836173
PLoS One. 2010 May 12;5(5):e10597
pubmed: 20485680
Cells. 2021 Jul 29;10(8):
pubmed: 34440696
Biochim Biophys Acta. 2008 Mar;1778(3):660-9
pubmed: 17854762
Development. 2013 Jun;140(12):2619-31
pubmed: 23637330
Glia. 2007 Nov 15;55(15):1565-76
pubmed: 17823970
Elife. 2019 Sep 05;8:
pubmed: 31486768
FEBS Lett. 2003 Nov 6;554(1-2):81-7
pubmed: 14596919
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3996-4003
pubmed: 19324864
Mol Biol Cell. 2012 Mar;23(6):1104-14
pubmed: 22262456
Invest Ophthalmol Vis Sci. 2007 Aug;48(8):3872-7
pubmed: 17652763

Auteurs

Andy Shao (A)

The University of Nevada, Reno School of Medicine, Reno, NV 89557, USA.
Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Antonio Jacobo Lopez (AJ)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

JiaJia Chen (J)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Addy Tham (A)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Seanne Javier (S)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Alejandra Quiroz (A)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Sonia Frick (S)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Edward M Levine (EM)

Department of Ophthalmology and Visual Sciences, Vanderbilt University, Nashville, TN 37235, USA.

K C Kent Lloyd (KCK)

Mouse Biology Program, UC Davis, Davis, CA 95616, USA.
Department of Surgery, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Brian C Leonard (BC)

Department of Surgical and Radiological Sciences, School of Veterinary Medicine, UC Davis, Davis, CA 95616, USA.

Christopher J Murphy (CJ)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.
Department of Surgical and Radiological Sciences, School of Veterinary Medicine, UC Davis, Davis, CA 95616, USA.

Thomas M Glaser (TM)

Department of Cell Biology and Human Anatomy, School of Medicine, UC Davis, Davis, CA 95616, USA.

Ala Moshiri (A)

Department of Ophthalmology and Vision Science, School of Medicine, UC Davis, Sacramento, CA 95817, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH